John Katzenellenbogen
Corporate Officer/Principal chez University of Illinois
Profil
John Katzenellenbogen is the founder of Radius Health, Inc. which was founded in 2003.
He is currently a Professor at the University of Illinois.
He holds a doctorate degree from Harvard University.
Postes actifs de John Katzenellenbogen
| Sociétés | Poste | Début |
|---|---|---|
| University of Illinois | Corporate Officer/Principal | - |
Anciens postes connus de John Katzenellenbogen
| Sociétés | Poste | Fin |
|---|---|---|
| RADIUS HEALTH, INC. | Fondateur | - |
Formation de John Katzenellenbogen
| Harvard University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |